Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use

被引:4
|
作者
Subramanian, Sreedhar [1 ]
Asher, Rebecca [2 ]
Weston, William [1 ]
Rimmer, Michael [1 ]
McConville, Adam [1 ]
Malin, Alex [1 ]
Jackson, Richard [2 ]
Collins, Paul [1 ]
Probert, Chris [3 ]
Dibb, Martyn [1 ]
Rhodes, Jonathan M. [3 ]
机构
[1] Royal Liverpool Univ Hosp, Dept Gastroenterol, Prescot St, Liverpool L7 8XP, Merseyside, England
[2] Canc Res UK, Liverpool Canc Trials Unit, Liverpool, Merseyside, England
[3] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England
关键词
inflammatory bowel disease; Crohn's disease; ulcerative colitis; patient-reported outcome; IBD-10; Harvey-Bradshaw index; simple clinical colitis activity index; QUALITY-OF-LIFE; CROHNS-DISEASE; ULCERATIVE-COLITIS; FECAL CALPROTECTIN; ACTIVITY INDEXES; QUESTIONNAIRE; THERAPY; FATIGUE; ADULTS; TOOL;
D O I
10.1097/MIB.0000000000000803
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background:Various physician- and patient-reported instruments exist for quantification of disease activity in inflammatory bowel diseases (IBD) but none are widely used in routine clinical practice. A simple patient-reported outcome measure might help inform clinical decision making. We evaluated a patient-reported 0 to 10 score of IBD activity (IBD-10) by correlation with conventional multicomponent activity indices.Methods:A single-center prospective cross-sectional study was conducted in ambulant patients with IBD. Patients were asked to verbally rate the control of Crohn's disease (CD) or ulcerative colitis (UC) on a numerical scale from 0 to 10, with 10 indicating perfect control. Disease activity was assessed using Harvey-Bradshaw index for CD and simple clinical colitis activity index for UC.Results:A total of 405 patients were included, of whom 209 (52%) had CD and 196 (48%) had UC. The median age was 41 (interquartile range, 27-55) years. IBD-10 correlated well with Harvey-Bradshaw Index (r(s) = -0.69, P < 0.001) and simple clinical colitis activity index (r(s) = -0.79, P < 0.001). An IBD-10 score of 7 predicted remission (defined by Harvey-Bradshaw index/simple clinical colitis activity index) with 90% sensitivity (95% confidence interval [CI], 86-94) and 75% specificity (95% CI, 67-82). The discriminatory ability of IBD-10 for remission was better for UC (area under the receiver operating characteristic curve, 0.93; 95% CI, 0.89-0.97) than for CD (area under the receiver operating characteristic curve, 0.86; 95% CI, 0.81-0.91; P = 0.035). An IBD-10 score of <7 correlated with treatment escalation.Conclusions:The IBD-10 score correlates well with more complex clinical activity indices. Correlation was less strong for CD than for UC, possibly reflecting a weaker link in CD between stool frequency and the patient perspective of disease activity. The IBD-10 score could readily be used in routine clinical practice.
引用
收藏
页码:1902 / 1907
页数:6
相关论文
共 50 条
  • [31] Patient-reported complementary and alternative medicine use in IBD: 10 years of observation among patients included in a national cohort
    Pittet, V.
    Aslan, N.
    Fournier, N.
    Decollogny, A.
    Schoepfer, A.
    Seibold, F.
    Rodondi, P-Y.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S401 - S402
  • [32] Examination of the relationship between disease activity, psychological distress and patient-reported outcome measures in an inflammatory bowel disease cohort
    Jackson, B.
    Con, D.
    Gorelik, A.
    Liew, D.
    De Cruz, P.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S467 - S467
  • [33] The IBD-Control questionnaire: German translation and validation of the standardized questionnaire for Patient Reported Outcome Measurement in inflammatory bowel disease
    Mueller, Annabell
    Bilger, Selina Simone
    Goeldi, Andreas
    Meinlschmidt, Gunther
    Rueter, Florian
    Kappes, Alexander
    Hruz, Petr
    Meier, Christoph Andreas
    Niess, Jan Hendrik
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (06): : 911 - 926
  • [34] Correlation between patient-reported disease activity, physician's global assessment and quality of life in Inflammatory Bowel Disease
    Lopes, S.
    Santos, I.
    Teixeira, M.
    Sequeira, C.
    Teixeira, C.
    Gamito, E.
    Alves, A. L.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I606 - I607
  • [35] Correlation between patient-reported outcome measures in inflammatory bowel disease and other measures of disease activity: a systematic review
    Calvet Calvo, X.
    Ferrario, M. G.
    Marfil Vives, V.
    Armenteros, S.
    Barreiro-de Acosta, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I772 - I773
  • [36] Validation of the 'Inflammatory Bowel Disease-Distribution, Chronicity, Activity [IBD-DCA] Score' for Ulcerative Colitis and Crohn′s Disease
    Lang-Schwarz, Corinna
    Angeloni, Miriam
    Agaimy, Abbas
    Atreya, Raja
    Becker, Christoph
    Dregelies, Theresa
    Danese, Silvio
    Flejou, Jean-Francois
    Gassler, Nikolaus
    Grabsch, Heike, I
    Hartmann, Arndt
    Kamaradova, Katerina
    Kuhl, Anja A.
    Lauwers, Gregory Y.
    Lugli, Alessandro
    Nagtegaal, Iris
    Neurath, Markus F.
    Oberhuber, Georg
    Peyrin-Biroulet, Laurent
    Rath, Timo
    Riddell, Robert
    Rubio, Carlos A.
    Sheahan, Kieran
    Siegmund, Britta
    Tilg, Herbert
    Villanacci, Vincenzo
    Westerhoff, Maria
    Ferrazzi, Fulvia
    Vieth, Michael
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (10): : 1621 - 1630
  • [37] Medication Utilization and the Impact of Continued Corticosteroid Use on Patient-reported Outcomes in Older Patients with Inflammatory Bowel Disease
    Geisz, Matthew
    Ha, Christina
    Kappelman, Michael D.
    Martin, Christopher F.
    Chen, Wenli
    Anton, Kristen
    Sandler, Robert S.
    Long, Millie D.
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (06) : 1435 - 1441
  • [38] Clinical strategies based on patient-reported outcomes and physicians' preferences to monitor biological therapy in inflammatory bowel disease
    Christensen, K. Risager
    Steenholdt, C.
    Naess-Schmidt, S. Buhl
    Brynskov, J.
    Ainsworth, M. A.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S294 - S294
  • [39] Medication Utilization and the Impact of Continued Corticosteroid Use on Patient-Reported Outcomes in Elderly Patients with Inflammatory Bowel Disease
    Geisz, Matthew
    Ha, Christina
    Kappelman, Michael
    Martin, Christopher
    Chen, Wenli
    Anton, Kristen
    Sandler, Robert
    Long, Millie
    INFLAMMATORY BOWEL DISEASES, 2016, 22 : S16 - S16
  • [40] Inflammatory bowel disease patient-reported quality assessment should drive service improvement: A national survey of UK IBD units and patients
    Hawthorne, A. Barney
    Glatter, Jackie
    Blackwell, Jonathan
    Ainley, Rachel
    Arnott, Ian
    Barrett, Kevin J.
    Bell, Graham
    Brookes, Matthew J.
    Fletcher, Melissa
    Muhammed, Rafeeq
    Nevill, Alan M.
    Segal, Jonathan
    Selinger, Christian P.
    Jones, Anja St Clair
    Younge, Lisa
    Lamb, Christopher A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (04) : 625 - 645